Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) is among the top 25 largest pharmaceutical companies in the United States. Founded in 1998, as Takeda's largest business unit outside of Japan, TPUSA / the U.S. Business Unit continues to be a key contributor to our global growth and success.
Striving toward better health is at the center of everything we do. Takeda is enjoying tremendous growth as an emerging global leader in the pharmaceutical industry, but remains ever mindful of our commitment to serve people worldwide by striving toward better health through leading innovation in medicine. The spirit of our commitment extends to our employees, partners and the larger community.
Founded in 1998, as Takeda's largest business unit outside of Japan, the U.S. Business Unit continues to be a key contributor to our global growth and success. We contribute to 30 percent of the company’s global revenues.
U.S. Business Unit focuses its efforts on medicines for the central nervous system (CNS) and gastroenterology (GI), with the recent FDA approvals of Trintellix and Entyvio, respectively.
95 Hayden Ave, Lexington, MA